Table 1.
Susceptibility patterns of Gram-negative bacilli isolated from the nasopharynx of children attending day-care centers of Goiânia from August to December 2005.
| Non-susceptible GNB | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Microorganism | N = 106 | % | S* | % | AMP | % | AMC | % | SXT | % | TET | % | MDR | % |
| Enterobacter aerogenes | 26 | 24.5 | 8 | 30.7 | 13 | 50.0 | 7 | 26.9 | 4 | 15.4 | 1 | 3.8 | 3 | 16.7 |
| Klebsiella pneumoniae | 17 | 16.0 | 0 | 0.0 | 17 | 100 | 4 | 23.5 | 5 | 29.4 | 4 | 23.5 | 6 | 35.3 |
| Escherichia coli | 11 | 10.4 | 5 | 45.4 | 0 | 0.0 | 1 | 9.0 | 5 | 45.4 | 3 | 27.3 | 3 | 50.0 |
| Enterobacter agglomerans | 8 | 7.5 | 4 | 50.0 | 4 | 50.0 | 1 | 12.5 | 0 | 0.0 | 1 | 12.5 | 1 | 25.0 |
| Pseudomonas aeruginosa | 4 | 3.8 | 0 | 0.0 | 4 | 100 | 4 | 100 | 4 | 100 | 0 | 0.0 | 4 | 100 |
| Enterobacter cloacae | 3 | 2.8 | 0 | 0.0 | 3 | 100 | 1 | 33.3 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
| Citrobacter freundii | 2 | 1.9 | 2 | 100 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
| Enterobacter gergoviae | 1 | 0.9 | 0 | 0.0 | 1 | 100 | 0 | 0.0 | 1 | 100 | 0 | 0.0 | 1 | 100 |
| Klebsiella oxytoca | 1 | 0.9 | 1 | 100 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
| Enterobacter sakazakii | 1 | 0.9 | 1 | 100 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
| Shigella sonnei | 1 | 0.9 | 1 | 100 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
| Enterobacter sp | 5 | 4.7 | – | – | – | – | – | – | – | – | – | – | – | – |
| Pseudomonas sp | 5 | 4.7 | – | – | – | – | – | – | – | – | – | – | – | – |
| GNB** | 21 | 19.8 | – | – | – | – | – | – | – | – | – | – | – | |
S*: Susceptibility to the antibiotics analyzed in the study (amikacin, amoxicillin-clavulanic acid, ampicillin, aztreonam, cefepime, cefotaxime, cefpodoxime, ceftazidime, ceftriaxone, ciprofloxacin, imipenem, meropenem, nalidixic acid, piperacillin-tazobactam, tetracycline, tobramycin, trimethoprim-sulfamethoxazole).
GNB**: Gram-negative bacilli isolated but not identified.
AMP = ampicillin, AMC = amoxicillin-clavulanic acid, SXT = trimethoprim-sulfamethoxazole, TET = tetracycline, MDR = multi-drug resistant microorganisms.